Fair Credit Reporting Act (1970)

The Fair Credit Reporting Act (FCRA) is a federal law enacted in 1970 to regulate the collection, dissemination, and use of consumer information, including credit reports. The law provides protections for consumers against inaccurate or outdated information that may be used to deny them employment, credit, insurance, or other benefits.

 

Key features of the FCRA include:

- Disclosure requirements: Employers must provide written notice to job applicants and employees if they plan to obtain a consumer report, such as a credit report or background check, and obtain their written consent before doing so.

 

·        Notification requirements: Employers must provide applicants and employees with a copy of the consumer report and a summary of their rights under the FCRA before taking any adverse action based on the report, such as denying employment or promotion.

 

·        Accuracy and privacy protections: Consumer reporting agencies must follow reasonable procedures to ensure the accuracy of the information they report, and must investigate and correct any errors promptly. The law also requires agencies to maintain reasonable procedures to protect the privacy and confidentiality of consumer information.

 

·        Dispute resolution process: The FCRA provides a process for consumers to dispute inaccurate or incomplete information in their credit reports or other consumer reports. The consumer reporting agency must investigate the dispute and, if necessary, correct or delete the information.

 

In terms of employee benefits, the FCRA impacts the use of consumer reports in making employment-related decisions, including decisions related to health insurance and other benefits. Employers must comply with the FCRA's disclosure and notification requirements when obtaining consumer reports for these purposes. Additionally, the law requires that any medical information obtained from a consumer report be kept confidential and used only for the purpose for which it was obtained.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.